Irwin Naturals Bringing Its Household Name Brand to the Psychedelic Mental Health SpaceTryp Therapeutics Announces Inclusion in AdvisorShares Psychedelics ETFMindMed and Liechti Lab Provide Results from their Psilocybin R&D CollaborationPsyched Wellness Announces Inclusion in AdvisorShares Psychedelics Exchange Traded Fund (ETF)Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating DisordersPsyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its NoveHow Will The Data Protection Ruling On Ketamine Impact Psychedelic Novel Drug Development Moving Forward?Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic AnalogsSilo Pharma Advances Psychedelic Patent PortfolioTryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of FloridaMajor Psychedelic Clinical Trial Data Is Right Around The CornerPsychedelic Drug Development Companies Are Leveraging Bolt On MedTech Acquisitions To Create A More Robust Patient Care 7 Psychedelic Clinical Trials Underway That Investors Should Keep On Their RadarNuminus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into PSilo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide PatentTryp Therapeutics Announces Q3 2021 Financial ResultsKetamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransWake Network, Inc. and the Lieber Institute for Brain Development Announce Research CollaborationTryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Join the top platform for cannabis stock analysis.

Premium Newsletter & Content Feed

A daily stream of market moving news, company announcements and earnings announcements keeps your finger on the pulse of the market.

Priority Access to Our Analysts

Have an urgent question on a stock, company, or trade? As a premium member, you have direct, priority access to our team.

Member’s Dashboard

Everything you need in one convenient, sleek dashboard. Access your premium news, market data, exclusive Mushroomstocks reports, and more.

What Members are Saying:

  • “In the crazy world of cannabis stocks, I’ve found Techincal420’s advice knowledge and invaluable. Techincal420’s team does a great job researching companies which helps me concentrate on the right companies. ” PAUL
  • “I read about technical 420 a couple months ago on a CNBC article… I was thrilled about Michael Berger’s idea of covering this seed-stage market since day one. Personally, I think the article undersold the value that Michael provides his subscribers. Michael is able to find value in an opaque market and rely that information in a way that is easy to understand and act on. If you want to invest in cannabis stocks, Mushroomstocks is the place to go!” ERALDO
  • “I want to thank Michael Berger for creating this resource. Similarly, I asked my Raymond James investment advisor about resources for investing in the Cannabis industry. I was given this website, among others. Out of all the resources I was given, Mushroomstocks without a doubt provides the most thorough and non-biased information on marijuana stocks and the cannabis industry. ” KAI
  • “Michael is a wiz when it comes to the stock market. I came to Mushroomstocks without any investment experience and Michael essentially tutored me and explained how everything works and why it works in the fashion it does. When it comes to the marijuana industry there is no one better. His cutting edge approach to this promising, yet opaque market is second to none. I would unquestionably recommend him to anyone who wants to learn about the marijuana stock industry.” NIMZJAB

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link